KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Accumulated Expenses (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Accumulated Expenses for 11 consecutive years, with $368.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses rose 20.16% year-over-year to $368.7 million, compared with a TTM value of $368.7 million through Sep 2025, up 20.16%, and an annual FY2024 reading of $307.8 million, up 5.07% over the prior year.
  • Accumulated Expenses was $368.7 million for Q3 2025 at Medpace Holdings, up from $323.5 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $368.7 million in Q3 2025 and bottomed at $29.0 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $230.6 million, with a median of $231.9 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses crashed 72.89% in 2021, then surged 434.47% in 2022.
  • Year by year, Accumulated Expenses stood at $159.3 million in 2021, then surged by 31.92% to $210.1 million in 2022, then surged by 39.42% to $293.0 million in 2023, then grew by 5.07% to $307.8 million in 2024, then grew by 19.8% to $368.7 million in 2025.
  • Business Quant data shows Accumulated Expenses for MEDP at $368.7 million in Q3 2025, $323.5 million in Q2 2025, and $286.1 million in Q1 2025.